Accepted at 3:28 p.m. Nov, 14, 2024 by Ahmed7
Author: HSNKA
Co-authors: thomas.holmes
Related Note: 1462849442061
Rationale for change

not mentioned on any card

Source: UWorld - Step 1 14136

Extra Extra
Text
GLP-1 agonists and DPP-4 inhibitors cause increased satiety via decreased {{c1::gastric emptying}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy




Watch Insulin, Sulfonylureas, Meglitinides, GLP-1 Agonists, DPP-4 Inhibitors
Sketchy 2


Watch Diabetes Management


Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Review GLP-1 Analogs




Review DPP-4 Inhibitors (Gliptins)
Physeo

Bootcamp
Watch associated Bootcamp video - Diabetes Type 2 Management
OME

Additional Resources

One by one
Empty field
#AK_Step1_v12::#B&B::08_Endocrinology::03_Pancreas::04_Treatment_of_Diabetes::Extra #AK_Step1_v12::#OME::PreClinical::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::01_Diabetes_mellitus_therapy::*GLP-1_Analogs #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::02_Diabetes_Management #AK_Step1_v12::#AMBOSS::02aeTP #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::01_DPP-4_Inhibitors #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::01_Diabetes_mellitus_therapy::*DPP-4_Inhibitors #AK_Step1_v12::#OME::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #AK_Step1_v12::#UWorld::Step::14136 #PANCE::ENDO::diabetes #AK_Step1_v12::#UWorld::COMLEX::26567 #AK_Step1_v12::#Bootcamp::Endocrinology::07_Pancreas::09_Diabetes_Type_2_Management #AK_Step1_v12::#UWorld::COMLEX::25889 #AK_Step2_v12::#B&B::04_Endocrinology::03_Diabetes::05_Diabetes_Treatment::Extra #AK_Step1_v12::#Physeo::09_Pharm::07_Endocrine::05_Amyline_Analogs_and_GLP-1_Analogs #AK_Step3_v12::#UWorld::107729 #AK_Step1_v12::#UWorld::Step::16324 #PANCE::EOR::PEDS #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::02_GLP-1_Analogs #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::08_Diabetes_Drugs_(Old)::07_GLP-1_Analogs #AK_Step1_v12::^Systems::Endocrine::Pharmacology #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::01_Insulin,_sulfonylureas,_meglitinides,_GLP-1_agonists,_DPP-4_inhibitors #AK_Step1_v12::#Physeo::09_Pharm::07_Endocrine::06_DDP-4_Inhibitors